Effects of alpelisib treatment on murine Pten-deficient lipomas

Phosphatase and tensin homolog (PTEN) hamartoma tumour syndrome (PHTS) is a rare disorder caused by germline mutations in the tumour suppressor gene PTEN, a key negative regulator of phosphatidylinositol 3-kinase (PI3K)/AKT signalling. Children with PHTS often develop lipomas, for which only surgica...

Full description

Saved in:
Bibliographic Details
Main Authors: Lea M. Merz, Karsten Winter, Sandy Richter, Sonja Kallendrusch, Andreas Horn, Sonja Grunewald, Nora Klöting, Kerstin Krause, Wieland Kiess, Diana Le Duc, Antje Garten
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Adipocyte
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/21623945.2025.2468275
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849763630835302400
author Lea M. Merz
Karsten Winter
Sandy Richter
Sonja Kallendrusch
Andreas Horn
Sonja Grunewald
Nora Klöting
Kerstin Krause
Wieland Kiess
Diana Le Duc
Antje Garten
author_facet Lea M. Merz
Karsten Winter
Sandy Richter
Sonja Kallendrusch
Andreas Horn
Sonja Grunewald
Nora Klöting
Kerstin Krause
Wieland Kiess
Diana Le Duc
Antje Garten
author_sort Lea M. Merz
collection DOAJ
description Phosphatase and tensin homolog (PTEN) hamartoma tumour syndrome (PHTS) is a rare disorder caused by germline mutations in the tumour suppressor gene PTEN, a key negative regulator of phosphatidylinositol 3-kinase (PI3K)/AKT signalling. Children with PHTS often develop lipomas, for which only surgical resection is available as treatment. We investigated the effects of the selective PI3K-inhibitor alpelisib on Pten-deficient lipomas. After incubation with alpelisib or the non-selective PI3K inhibitor wortmannin, we analysed histology, gene expression, and Pi3k pathway in lipoma and control epididymal adipose tissue (epiWAT). Alpelisib increased adipocyte area in lipomas compared to epiWAT. Baseline gene expression showed higher levels of markers for proliferation (Pcna), fibrosis (Tgfb1), and adipogenesis (Pparg) in lipomas, while hormone-sensitive lipase expression was lower than in epiWAT. Following alpelisib incubation, target genes of Pi3k signalling and extracellular matrix factors were reduced. We confirmed Pi3k inhibition through detecting decreased Akt levels compared to control treatment. Human lipoma samples treated with alpelisib showed variable lipolysis responses, suggesting variability in therapeutic outcomes. We established an ex vivo model to study alpelisib effects on Pten-deficient lipomas. These results underscore the therapeutic potential of targeted PI3K inhibition in the treatment of PHTS-associated lipomas, particularly in cases that are inoperable.
format Article
id doaj-art-111da89f7bcb42d1bac088c500e1dc4d
institution DOAJ
issn 2162-3945
2162-397X
language English
publishDate 2025-12-01
publisher Taylor & Francis Group
record_format Article
series Adipocyte
spelling doaj-art-111da89f7bcb42d1bac088c500e1dc4d2025-08-20T03:05:21ZengTaylor & Francis GroupAdipocyte2162-39452162-397X2025-12-0114110.1080/21623945.2025.2468275Effects of alpelisib treatment on murine Pten-deficient lipomasLea M. Merz0Karsten Winter1Sandy Richter2Sonja Kallendrusch3Andreas Horn4Sonja Grunewald5Nora Klöting6Kerstin Krause7Wieland Kiess8Diana Le Duc9Antje Garten10Center for Pediatric Research, University Hospital for Children & Adolescents, Leipzig University, Leipzig, GermanyInstitute of Anatomy, Leipzig University, Leipzig, GermanyCenter for Pediatric Research, University Hospital for Children & Adolescents, Leipzig University, Leipzig, GermanyInstitute of Anatomy, Leipzig University, Leipzig, GermanyInstitute of Anatomy, Leipzig University, Leipzig, GermanyDepartment for Dermatology, Venereology and Allergology, University Hospital Leipzig, Leipzig, GermanyHelmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG), Helmholtz Center Munich at the University and University Hospital Leipzig, Leipzig, GermanyDepartment of Endocrinology, Nephrology and Rheumatology, University Hospital Leipzig, Leipzig, GermanyCenter for Pediatric Research, University Hospital for Children & Adolescents, Leipzig University, Leipzig, GermanyInstitute of Human Genetics, University Hospital Leipzig, Leipzig, GermanyCenter for Pediatric Research, University Hospital for Children & Adolescents, Leipzig University, Leipzig, GermanyPhosphatase and tensin homolog (PTEN) hamartoma tumour syndrome (PHTS) is a rare disorder caused by germline mutations in the tumour suppressor gene PTEN, a key negative regulator of phosphatidylinositol 3-kinase (PI3K)/AKT signalling. Children with PHTS often develop lipomas, for which only surgical resection is available as treatment. We investigated the effects of the selective PI3K-inhibitor alpelisib on Pten-deficient lipomas. After incubation with alpelisib or the non-selective PI3K inhibitor wortmannin, we analysed histology, gene expression, and Pi3k pathway in lipoma and control epididymal adipose tissue (epiWAT). Alpelisib increased adipocyte area in lipomas compared to epiWAT. Baseline gene expression showed higher levels of markers for proliferation (Pcna), fibrosis (Tgfb1), and adipogenesis (Pparg) in lipomas, while hormone-sensitive lipase expression was lower than in epiWAT. Following alpelisib incubation, target genes of Pi3k signalling and extracellular matrix factors were reduced. We confirmed Pi3k inhibition through detecting decreased Akt levels compared to control treatment. Human lipoma samples treated with alpelisib showed variable lipolysis responses, suggesting variability in therapeutic outcomes. We established an ex vivo model to study alpelisib effects on Pten-deficient lipomas. These results underscore the therapeutic potential of targeted PI3K inhibition in the treatment of PHTS-associated lipomas, particularly in cases that are inoperable.https://www.tandfonline.com/doi/10.1080/21623945.2025.2468275Adipose tissuephosphatidylinositol 3-kinasephosphatase and tensin homologtissue slice culturewortmannin
spellingShingle Lea M. Merz
Karsten Winter
Sandy Richter
Sonja Kallendrusch
Andreas Horn
Sonja Grunewald
Nora Klöting
Kerstin Krause
Wieland Kiess
Diana Le Duc
Antje Garten
Effects of alpelisib treatment on murine Pten-deficient lipomas
Adipocyte
Adipose tissue
phosphatidylinositol 3-kinase
phosphatase and tensin homolog
tissue slice culture
wortmannin
title Effects of alpelisib treatment on murine Pten-deficient lipomas
title_full Effects of alpelisib treatment on murine Pten-deficient lipomas
title_fullStr Effects of alpelisib treatment on murine Pten-deficient lipomas
title_full_unstemmed Effects of alpelisib treatment on murine Pten-deficient lipomas
title_short Effects of alpelisib treatment on murine Pten-deficient lipomas
title_sort effects of alpelisib treatment on murine pten deficient lipomas
topic Adipose tissue
phosphatidylinositol 3-kinase
phosphatase and tensin homolog
tissue slice culture
wortmannin
url https://www.tandfonline.com/doi/10.1080/21623945.2025.2468275
work_keys_str_mv AT leammerz effectsofalpelisibtreatmentonmurineptendeficientlipomas
AT karstenwinter effectsofalpelisibtreatmentonmurineptendeficientlipomas
AT sandyrichter effectsofalpelisibtreatmentonmurineptendeficientlipomas
AT sonjakallendrusch effectsofalpelisibtreatmentonmurineptendeficientlipomas
AT andreashorn effectsofalpelisibtreatmentonmurineptendeficientlipomas
AT sonjagrunewald effectsofalpelisibtreatmentonmurineptendeficientlipomas
AT norakloting effectsofalpelisibtreatmentonmurineptendeficientlipomas
AT kerstinkrause effectsofalpelisibtreatmentonmurineptendeficientlipomas
AT wielandkiess effectsofalpelisibtreatmentonmurineptendeficientlipomas
AT dianaleduc effectsofalpelisibtreatmentonmurineptendeficientlipomas
AT antjegarten effectsofalpelisibtreatmentonmurineptendeficientlipomas